Zhang, W., Yu, W., Cai, G., Zhu, J., Zhang, C., Li, S., . . . Kong, L. (2021). Retraction Note to: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy. Cell death & disease, 12(6), 522-1. https://doi.org/10.1038/s41419-021-03809-2
Chicago Style (17th ed.) CitationZhang, Wenda, et al. "Retraction Note to: A New Synthetic Derivative of Cryptotanshinone KYZ3 as STAT3 Inhibitor for Triple-negative Breast Cancer Therapy." Cell Death & Disease 12, no. 6 (2021): 522-1. https://doi.org/10.1038/s41419-021-03809-2.
MLA (9th ed.) CitationZhang, Wenda, et al. "Retraction Note to: A New Synthetic Derivative of Cryptotanshinone KYZ3 as STAT3 Inhibitor for Triple-negative Breast Cancer Therapy." Cell Death & Disease, vol. 12, no. 6, 2021, pp. 522-1, https://doi.org/10.1038/s41419-021-03809-2.